MDS-482 Impact Of Magrolimab in Combination With Azacitidine on Red Blood Cells (RBCs) in Patients With Higher-Risk Myelodysplastic Syndromes (HR MDS) (2022)

First Author: Chen J
Attributed to:  University of Oxford – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2152-2650(22)01421-5

Publication URI: https://api.elsevier.com/content/abstract/scopus_id/85138192854

Type: Journal Article/Review

Parent Publication: Clinical Lymphoma Myeloma and Leukemia